Samsung Biologics Co Ltd
KRX:207940
Samsung Biologics Co Ltd
KRX:207940
Price:
736 000 KRW
-1.87%
Market Closed
Updated:
Jun 10, 2024
Samsung Biologics Co Ltd
Net Issuance of Debt
|
Samsung Biologics Co Ltd
Net Issuance of Debt Peer Comparison
Comparables:
P
087010
S
237690
F
220100
L
141080
C
268600
Competitive Net Issuance of Debt Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Samsung Biologics Co Ltd
KRX:207940
|
Net Issuance of Debt
-₩751.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Net Issuance of Debt
-₩99.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Net Issuance of Debt
₩80.5B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
F
|
FutureChem Co Ltd
KOSDAQ:220100
|
Net Issuance of Debt
-₩1.2B
|
CAGR 3-Years
39%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Net Issuance of Debt
-₩268.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-132%
|
CAGR 10-Years
N/A
|
|
C
|
Cellivery Therapeutics Inc
KOSDAQ:268600
|
Net Issuance of Debt
₩3.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Samsung Biologics Co Ltd's Net Issuance of Debt?
Net Issuance of Debt
-751.6B
KRW
-751.6B
KRW
Based on the financial report for Mar 31, 2024, Samsung Biologics Co Ltd's Net Issuance of Debt amounts to -751.6B KRW.
What is Samsung Biologics Co Ltd's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 1Y
-176%
-176%
Over the last year, the Net Issuance of Debt growth was -176%.
You don't have any saved screeners yet
